Clinical Trial Update: Natesto Testosterone Nasal Gel for Hypogonadal Men [Phase 4]

View source ↗

Summary

Phase 4 trial of Natesto testosterone nasal gel for hypogonadal men has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Sexual Dysfunction

Drugs mentioned

• NATESTO (testosterone)

Snippet

Sponsor: University of Utah | Conditions: Erectile Dysfunction, Sexual Dysfunction | Phase 4 | Status: WITHDRAWN